Crossmark

Development of an Innovative Quality by Design (QbD) Based Stability-Indicating HPLC Method and its Validation for Clofazimine from its Bulk and Pharmaceutical Dosage Forms

Crossref DOI link: https://doi.org/10.1007/s10337-018-3660-8

Published Online: 2018-11-23

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Patil, Tulshidas S.

Deshpande, Ashwini S. https://orcid.org/0000-0001-5548-3140
License Information

Text and Data Mining valid from 2018-11-23
More Information

Article History

Received: 11 August 2018

Revised: 19 October 2018

Accepted: 15 November 2018

First Online: 23 November 2018

Compliance with ethical standards

:

: Authors declare no conflict of interest.

: The present work is in compliance with ethical standards.

Document is current

Any future updates will be listed below